NCT03402490

Brief Summary

The aim of our pilot study is to evaluate the feasibility, acceptance and efficacy of motivational interviewing (MI) to support elderly patients with heart failure with preserved ejection fraction (HFpEF) in maintaining or starting physical activity (PA).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2015

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2017

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 18, 2018

Completed
Last Updated

January 18, 2018

Status Verified

January 1, 2018

Enrollment Period

2.5 years

First QC Date

December 22, 2017

Last Update Submit

January 17, 2018

Conditions

Keywords

Motivational interviewingphysical activityfeasibilityHFpEF

Outcome Measures

Primary Outcomes (4)

  • Adherence to intervention

    To evaluate the feasibility of motivational counseling to enhance physical activity patients´ adherence to appointments is assessed as number / percentage of sessions attended

    Over 6 month intervention period

  • Patient acceptance of intervention

    To assess how patients evaluate the Intervention, i.e. receiving motivational counseling, they were asked to fill in evaluation sheets

    At 6-month assessment

  • Effectiveness (peak VO2)

    Changes in the maximal exercise capacity (peak VO2) during a symptom-limited cardiopulmonary exercise test on a bicycle ergometer.

    Change from baseline to 6-month assessment

  • Effectiveness (6-minute walk distance)

    Six-minutes walking distance

    Change from baseline to 6-month assessment

Other Outcomes (2)

  • Motivation

    Change from baseline to 6-month assessment.

  • Physical activity

    Change from baseline to 6-month assessment.

Study Arms (2)

Motivational interviewing

EXPERIMENTAL

Over a time span of 6 months, participants in the intervention group received up to 7 sessions of motivational counseling, lasting 15-30 minutes each, to enhance physical activity.

Behavioral: Motivational interviewing

Usual care

NO INTERVENTION

Participants who served as controls received usual care.

Interventions

Motivational interviewing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • preserved left ventricular systolic function (left ventricular ejection fraction \>= 50%),
  • echocardiographically determined diastolic dysfunction (grade ≥ 1),
  • New York Heart association functional classes I, II or III,
  • at least one cardiovascular risk-factor (overweight, diabetes, hypertension, smoking or hyperlipidemia)
  • participation in Ex-DHF main study
  • written informed consent

You may not qualify if:

  • Non-cardiac causes for heart failure-like symptoms
  • Chronic obstructive pulmonary disease GOLD stages ≥II
  • Anaemia (haemoglobin \<11 mg/dL)
  • Significant renal dysfunction (eGFR \<30 mL/min/1.73 m\*\*2 indexed to BSA)
  • Significant peripheral artery disease (Fontaine ≥IIb)
  • Musculoskeletal disease that contributes to reduced exercise performance
  • Specific cardiomyopathy (e.g. amyloidosis)
  • Haemodynamically significant valvular disorders
  • Significant coronary artery disease (current angina pectoris Canadian Cardiovascular Society Class ≥II or positive stress test, myocardial infarction or coronary artery bypass graft within the last 3 months)
  • Any inability or contraindication to participate in cardiopulmonary exercise testing or in an exercise programme (e.g. physiological, mental) or to supply essential information (e.g. questionnaire, diary)
  • Ineffective control of resting blood pressure (≥140/90 mmHg or ≥160/100 mmHg with ≥3 antihypertensive drugs) or of resting heart rate (≥100 b.p.m.)
  • Expected low adherence (e.g. by travel distance to trial site; planned absences longer than 4 weeks during follow-up) or ongoing drug abuse
  • Pregnant or nursing women
  • Concomitant participation in other interventional clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure, DiastolicMotor Activity

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: One group of participants received motivational counseling to enhance physical activity; the other group received usual care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

December 22, 2017

First Posted

January 18, 2018

Study Start

June 18, 2013

Primary Completion

December 8, 2015

Study Completion

December 8, 2015

Last Updated

January 18, 2018

Record last verified: 2018-01